GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 70.07B
Enterprise value 87.41B
Trailing P/E 12.59
Forward P/E 9.16
PEG ratio (5-yr expected) 1.30
Price/sales (ttm)1.93
Price/book (mrq)4.75
Enterprise value/revenue 3.01
Enterprise value/EBITDA 10.12

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-19.48%
S&P500 52-week change 314.65%
52-week high 322.67
52-week low 313.48
50-day moving average 317.98
200-day moving average 316.95

Share statistics

Avg vol (3-month) 32.38k
Avg vol (10-day) 33.93k
Shares outstanding 54.09B
Implied shares outstanding 6N/A
Float 83.92B
% held by insiders 11.75%
% held by institutions 143.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.7
Forward annual dividend yield 44.12%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 33.39%
5-year average dividend yield 45.27
Payout ratio 456.30%
Dividend date 309 Jan 2019
Ex-dividend date 417 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 50.35%
Operating margin (ttm)25.93%

Management effectiveness

Return on assets (ttm)6.36%
Return on equity (ttm)28.17%

Income statement

Revenue (ttm)29.08B
Revenue per share (ttm)7.21
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)19.92B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)1.35
Quarterly earnings growth (yoy)-17.30%

Balance sheet

Total cash (mrq)6.98B
Total cash per share (mrq)1.72
Total debt (mrq)20.91B
Total debt/equity (mrq)184.80
Current ratio (mrq)0.95
Book value per share (mrq)2.92

Cash flow statement

Operating cash flow (ttm)4.91B
Levered free cash flow (ttm)3.39B